drugset / Trial / NCT00717145
Food Effects on the Relative Bioavailability of Different Dosages of Risedronate
RandomizedCrossoverOpen-label
Summary
Randomized, open-label, multi-center, 4-treatment, 4-period crossover study. The study will consist of a screening visit, study center admission (preceding Treatment Periods 1, 2, 3, and 4), 4 treatment periods (4 days each), 3 washout periods (14 to 17 days in duration separating each treatment period), and exit procedures.
Timeline
- Start
- 2008-07
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 20 mg | — |
| Subject | Risedronate | Small molecule | 35 mg | — |
Indications
No indication recorded.